menu

Slide

Investments in unique diagnostic technologies for the era of precision medicine

Scroll Down
Scroll Down
GEHA MENTAL HEALTH CENTER AND GENETIKA+ PARTNER ON NOVEL SOLUTIONS DRIVING PRECISION MEDICINE IN DEPRESSION

READ MORE

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer’s Disease

READ MORE

Hummingbird Diagnostics Announces Publication Evaluating miR-Blood’s Small RNA Expression Dataset Capabilities in Nature’s Scientific Data

READ MORE

Hummingbird Diagnostics GmbH to Unveil Pioneering Alzheimer’s Disease Biomarker Research at CTAD Conference

READ MORE

GreyBird Ventures

is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach.

MEET THE PEOPLE

For additional information, please contact: greybird@greybirdventures.com

DISCLAIMER